森铁能治疗上消化道出血后贫血的疗效评价

目的探讨森铁能(蔗糖铁注射液)治疗上消化道出血所致的失血性贫血的临床疗效。方法上消化道出血的患者共68例,将其分为两组,森铁能治疗组36例和对照组32例。对照组进行常规治疗,治疗组在常规治疗基础上加用森铁能200 mg,隔日1次,治疗1周后复查血常规和网织红细胞。结果治疗组贫血改善明显,治疗后两组的血红蛋白分别为(96.11±14.27)g/L和(89.25±13.29)g/L;两组的红细胞分别为(3.31±0.54)×1012/L和(3.01±0.45)×1012/L;两组的红细胞比容分别为0.30±0.04和0.28±0.45,两组比较差异有统计学意义。结论森铁能在失血性贫血的治疗上有明显的作用。

The Effect of Intravenous Iron Sucrose on the Anemia Patients after Upper Gastrointestinal Hemorrhage

Objective To explore the efficacy of intravenous iron sucrose on the anemia patients after upper gastrointestinal hemorrhage. Methods A total of 68 patients were divided into control group and treatment group. The control group received basic treatment, while the treatment group received intravenous iron sucrose （200 mg, Qod）. The blood routine and reticular erythrocytes （Ret） were checked after one week. Resuits The hemoglobulin （Hb）in the iron sucrose group is（ 96.11± 14.27 ）g/L while the Hb of control is （ 89.25 ± 13.29 ） g/L. Red blood cell （ RBC ） in the iron sucrose group is （ 3.31± 0.54 ） ×10^12/Lwhile the RBC of control is（3.01 ±0.45 ） ×10^12/L）. Haematocrit （HCT） in the iron sucrose group is 0.30± 0.04 while HCT of control is 0.28 ± 0.45. The difference was significant. Conclusion Intravenous iron sucrose is effective in treating anemic patients after upper gastrointestinal hemorrhage.